Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Nat Immunol. 2011 Jan;12(1):37-44. doi: 10.1038/ni.1963. Epub 2010 Nov 21.
The poly(ADP-ribose) polymerases (PARPs) participate in many biological and pathological processes. Here we report that the PARP-13 shorter isoform (ZAPS), rather than the full-length protein (ZAP), was selectively induced by 5'-triphosphate-modified RNA (3pRNA) and functioned as a potent stimulator of interferon responses in human cells mediated by the RNA helicase RIG-I. ZAPS associated with RIG-I to promote the oligomerization and ATPase activity of RIG-I, which led to robust activation of IRF3 and NF-κB transcription factors. Disruption of the gene encoding ZAPS resulted in impaired induction of interferon-α (IFN-α), IFN-β and other cytokines after viral infection. These results indicate that ZAPS is a key regulator of RIG-I signaling during the innate antiviral immune response, which suggests its possible use as a therapeutic target for viral control.
多聚(ADP-核糖)聚合酶(PARPs)参与许多生物和病理过程。在这里,我们报告 PARP-13 的较短异构体(ZAPS),而不是全长蛋白(ZAP),被 5'-三磷酸修饰的 RNA(3pRNA)选择性诱导,并作为人类细胞中 RNA 解旋酶 RIG-I 介导的干扰素反应的有效刺激物发挥作用。ZAPS 与 RIG-I 结合,促进 RIG-I 的寡聚化和 ATPase 活性,从而导致 IRF3 和 NF-κB 转录因子的强烈激活。破坏编码 ZAPS 的基因会导致病毒感染后干扰素-α(IFN-α)、IFN-β 和其他细胞因子的诱导受损。这些结果表明,ZAPS 是先天抗病毒免疫反应中 RIG-I 信号的关键调节剂,这表明它可能被用作病毒控制的治疗靶标。